Loading...

National Institute of Mental Health Data Archive (NDA) Sign In
NDA

Enter the email address associated with your existing NDA Account and click Continue Linking Process.

If you do not have an existing NDA account, click Go Back.

Warning Notice This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action. All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.
National Institute of Mental Health Data Archive (NDA) Sign In
NDA

Success! An email is on its way!

Please check your email to complete the linking process. The link you receive is only valid for 30 minutes.

Check your spam or junk folder if you do not receive the email in the next few minutes.

Warning Notice This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action. All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.
Create or Link an Existing NDA Account

Warning Notice

This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action. All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.

NIMH Data Archive (NDA) Sign In or Create An Account
Update Password

You have logged in with a temporary password. Please update your password. Passwords must contain 8 or more characters and must contain at least 3 of the following types of characters:

  • Uppercase
  • Lowercase
  • Numbers
  • Special Characters limited to: %,_,!,@,#,$,-,%,&,+,=,),(,*,^,:,;
Update Password

Subscribe to our mailing list

Mailing List(s)
Email Format

You are now leaving the NIMH Data Archive (NDA) web site to go to:

Click on the address above if the page does not change within 10 seconds.

Disclaimer

NDA is not responsible for the content of this external site and does not monitor other web sites for accuracy.

Accept Terms
Data Access Terms - Decline Terms

Are you sure you want to cancel? This will decline terms and you will not be authorized for access.

NIMH Data Archive
NDA ABCD CCF OAI NIAAADA AMP SCZ HEAL

Comprehensive Post-Session Questionnaire

24 Shared Subjects

N/A
Clinical Assessments
Questionnaire
01/02/2018
cpsq01
01/03/2018
View Change History
01
Definition
Submission Template
Query Element Name Data Type Size Required Description Value Range Notes Aliases
subjectkey GUID Required The NDAR Global Unique Identifier (GUID) for research subject NDAR*
src_subject_id String 20 Required Subject ID how it's defined in lab/project
interview_date Date Required Date on which the interview/genetic test/sampling/imaging/biospecimen was completed. MM/DD/YYYY
interview_age Integer Required Age in months at the time of the interview/test/sampling/imaging. 0::1440 Age is rounded to chronological month. If the research participant is 15-days-old at time of interview, the appropriate value would be 0 months. If the participant is 16-days-old, the value would be 1 month.
sex String 20 Required Sex of subject at birth M;F; O; NR M = Male; F = Female; O=Other; NR = Not reported gender
cpsq01 Integer Recommended To what extent did you experience tingling DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq02 Integer Recommended To what extent did you experience an itching sensation DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq03 Integer Recommended To what extent did you experience a burning sensation DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq04 Integer Recommended To what extent did you experience pain DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq05 Integer Recommended To what extent did you experience fatigue DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq06 Integer Recommended To what extent did you experience nervousness DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq07 Integer Recommended To what extent did you experience headache DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq08 Integer Recommended To what extent did you experience difficulty concentrating DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq09 Integer Recommended To what extent did you experience a mood change DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq10 Integer Recommended To what extent did you experiencechange in your vision/visual perception DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq11 Integer Recommended To what extent did you experience visual sensation (seeing lights for example) associated with the start or end of stimulation/the stimulation DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq12 Integer Recommended Other effects DURING tDAS/tACS 0::10 Higher number indicates greater symptom severity
cpsq13 String 100 Recommended Describe other effects DURING tDAS/tACS
cpsq14 Integer Recommended To what extent did you experience tingling AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq15 Integer Recommended To what extent did you experience an itching sensation AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq16 Integer Recommended To what extent did you experience a burning sensation AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq17 Integer Recommended To what extent did you experience pain AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq18 Integer Recommended To what extent did you experience fatigue AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq19 Integer Recommended To what extent did you experience nervousness AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq20 Integer Recommended To what extent did you experience headache AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq21 Integer Recommended To what extent did you experience difficulty concentrating AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq22 Integer Recommended To what extent did you experience a mood change AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq23 Integer Recommended To what extent did you experiencechange in your vision/visual perception AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq24 Integer Recommended Other effects AFTER tDAS/tACS 0::10 Higher number indicates greater symptom severity
cpsq25 String 100 Recommended Describe other effects AFTER tDAS/tACS
cpsq26 Integer Recommended To what extent did you experience tingling in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq27 Integer Recommended To what extent did you experience an itching sensation in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq28 Integer Recommended To what extent did you experience a burning sensation in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq29 Integer Recommended To what extent did you experience pain in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq30 Integer Recommended To what extent did you experience fatigue in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq31 Integer Recommended To what extent did you experience nervousness in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq32 Integer Recommended To what extent did you experience headache in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq33 Integer Recommended To what extent did you experience difficulty concentrating in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq34 Integer Recommended To what extent did you experience a mood change in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq35 Integer Recommended To what extent did you experiencechange in your vision/visual perception in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq36 Integer Recommended To what extent did you experience visual sensation (seeing lights for example) associated with the start or end of stimulation/the stimulation in the WEEK PRIOR to tDCS/Tacs 0::10 Higher number indicates greater symptom severity
cpsq37 Integer Recommended Other effects in the WEEK PRIOR to tDAS/tACS 0::10 Higher number indicates greater symptom severity
cpsq38 String 100 Recommended Describe other effects in the WEEK PRIOR to tDAS/tACS
Data Structure

This page displays the data structure defined for the measure identified in the title and structure short name. The table below displays a list of data elements in this structure (also called variables) and the following information:

  • Element Name: This is the standard element name
  • Data Type: Which type of data this element is, e.g. String, Float, File location.
  • Size: If applicable, the character limit of this element
  • Required: This column displays whether the element is Required for valid submissions, Recommended for valid submissions, Conditional on other elements, or Optional
  • Description: A basic description
  • Value Range: Which values can appear validly in this element (case sensitive for strings)
  • Notes: Expanded description or notes on coding of values
  • Aliases: A list of currently supported Aliases (alternate element names)
  • For valid elements with shared data, on the far left is a Filter button you can use to view a summary of shared data for that element and apply a query filter to your Cart based on selected value ranges

At the top of this page you can also:

  • Use the search bar to filter the elements displayed. This will not filter on the Size of Required columns
  • Download a copy of this definition in CSV format
  • Download a blank CSV submission template prepopulated with the correct structure header rows ready to fill with subject records and upload

Please email the The NDA Help Desk with any questions.

Additional Information
Training Privacy Policy Disclaimer Contact Us
External Resources
Accessibility FOIA OIG HHS Vulnerability Disclosure
NIH Logo HHS Logo USA Gov Logo
4d04865a98436a58f1a2a6c5d744acef99e2441f